Nippon’s bid for US Steel in Joe Biden’s hands after panel vetting deal deadlocked - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
日本制铁

Nippon’s bid for US Steel in Joe Biden’s hands after panel vetting deal deadlocked

President has already voiced opposition to Japanese company’s takeover plan
00:00

{"text":[[{"start":14.06,"text":"A US panel vetting Nippon Steel’s proposed takeover of US Steel has been unable to agree on whether President Joe Biden should support the $15bn deal, making it more likely that he will block it during his last weeks in office. "}],[{"start":26.67,"text":"The Committee on Foreign Investment in the US (Cfius) reported to the White House on Monday that the nine agencies on the panel had not reached consensus that the deal posed no security risks, according to Nippon Steel and a person familiar with the matter. "},{"start":40.474000000000004,"text":"Monday was the deadline for Cfius to make a decision. "}],[{"start":44.94,"text":"The lack of agreement puts the decision on a combination — which was agreed more than a year ago — in the hands of Biden, who has already voiced opposition to the Japanese company’s takeover plan and is widely expected to block it. "}],[{"start":57.28,"text":"Doing so would have been more difficult for the president to justify if Cfius had concluded that a takeover did not pose any national security concerns. "}],[{"start":65.72,"text":"Under the rules, the president has 15 days to make a decision or extend the timeline, which could hand the responsibility to Donald Trump, who has also publicly opposed the bid. "}],[{"start":75.62,"text":"The deal’s collapse could shake faith in the strength of the most important alliance between the US and an Asia-Pacific country, and risk revealing the shortcomings of a national security process that has become highly politicised, according to government officials on both sides. "}],[{"start":89.74000000000001,"text":"The inter-agency investment screening body said allowing a Nippon Steel takeover of US Steel could result in lower domestic steel production, posing “a national security risk”, according to the person familiar with its conclusion. "}],[{"start":102.68,"text":"Nippon Steel confirmed that Cfius had referred the decision to the US president after failing to reach consensus. "}],[{"start":110.01,"text":"The company urged Biden to “reflect on the great lengths that we have gone to address any national security concerns”. "}],[{"start":116.14,"text":"It added that it had made commitments to “grow US Steel, protect American jobs and strengthen the entire steel industry” and it was confident that the transaction should be accepted “if it is fairly evaluated on its merits”. "}],[{"start":127.76,"text":"The Cfius committee was split on whether the remedies proposed by Nippon Steel to guarantee these outcomes, such as appointing US citizens to top management and board positions, would be enough, the person familiar with the outcome said. "}],[{"start":141.33,"text":"A White House spokesperson said: “We received the Cfius evaluation and the president will review it. ”"}],[{"start":147.99,"text":"The US Treasury, which chairs the Cfius panel, referred questions to the White House. "}],[{"start":153.83,"text":"The Financial Times previously reported that the main source of opposition to the deal in the Cfius panel came from Katherine Tai, the US trade representative, even though agencies on the panel had concluded that the acquisition of the iconic American steel producer posed no security risks. "}],[{"start":169.65,"text":"Nippon Steel has left the door open for a legal battle with the US government should the deal get rejected. "}],[{"start":176.04,"text":"Takahiro Mori, vice-president at Nippon Steel, had been on a last-minute charm offensive, flying between Washington and Pennsylvania in recent weeks to try to win over policymakers and steelworkers. "}],[{"start":187.93,"text":"A key obstacle has been fierce opposition from United Steelworkers, a powerful trade union led by David McCall, who is close to Biden. "}],[{"start":195.41,"text":""}]],"url":"https://creatives.ftmailbox.cn/album/186269-1735016140.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

Odyssey筹资逾3亿美元,生物技术公司正式上市

自身免疫性疾病药物开发商Odyssey Therapeutics表示,其首次公开募股共筹集了2.79亿美元。
13小时前

特朗普计划解雇美国食品药品监督管理局局长

此举将加剧这一药品监管机构的动荡,并给生物科技行业的药品审批前景蒙上阴影。
8分钟前

Lex专栏:AI科技蓝筹股亮眼表现掩盖其他角落的黯淡

42只股票推动了标普指数的大部分回报,经济形态正逐渐分化为AI经济与非AI经济。

Odyssey融资超3亿美元,生物科技公司即将上市

自身免疫性疾病药物开发商Odyssey Therapeutics周四晚间表示,其通过首次公开募股筹集了2.79亿美元。
17小时前

法律AI初创公司为律师开辟的另类职业路径

AI热潮正在为初级和资深律师开辟一条另类的职业路径:加入法律科技初创公司工作,且往往还能获得股权。

苹果、伯克希尔与耐心的美德

这两家公司等待绝佳机遇的耐心策略曾经奏效,但如今却愈发困难。
设置字号×
最小
较小
默认
较大
最大
分享×